ClinicalTrials.Veeva

Menu
W

Western Health | Western Health Renal Research

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tafasitamab
Lenalidomide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. (InMIND)

This is a Phase 3 double-blind, placebo-controlled, randomized study designed to investigate whether tafasitamab and lenalidomide as an add-on to rit...

Active, not recruiting
Marginal Zone Lymphoma
Follicular Lymphoma
Drug: tafasitamab
Drug: placebo

The aim of this randomised, double-blind, placebo controlled clinical food trial is to determine if the medical food SBD121 Synbiotic (prebiotic and...

Enrolling
Rheumatoid Arthritis
Other: Placebo
Other: SBD121

Trial sponsors

Incyte logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems